for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Relx PLC

REL.L

Latest Trade

1,722.50GBp

Change

-3.50(-0.20%)

Volume

3,433,190

Today's Range

1,704.50

 - 

1,741.00

52 Week Range

1,382.86

 - 

2,109.00

As of on the London Stock Exchange (LON) ∙ Minimum 15 minute delay

Pricing

Previous Close
1,726.00
Open
1,728.50
Volume
3,433,190
3M AVG Volume
59.69
Today's High
1,741.00
Today's Low
1,704.50
52 Week High
2,109.00
52 Week Low
1,382.86
Shares Out (MIL)
1,931.86
Market Cap (MIL)
33,343.83
Forward P/E
20.98
Dividend (Yield %)
2.65

Next Event

Full Year 2020 Relx PLC Earnings Release

Latest Developments

More

Relx Says Paul Walker To Succeed Anthony Habgood As Chair

Relx Posts HY Adjusted Operating Profit Of £939 Mln

Cirium Says Snowflake Software Has Signed Agreement To Become Part Of Cirium

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Relx PLC

RELX PLC is a holding company of RELX Group plc. RELX Group is a global provider of information and analytics for professional and business customers across industries. The Company operates in four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal, and Exhibitions. The Company's Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals progress science and advance healthcare. The Risk & Business Analytics segment provides solutions and decision tools that combine public and industry-specific content with technology and analytics. The Legal segment is a provider of information and analytics to professionals in legal, corporate, and government organizations. Its Exhibitions segment consists of Reed Exhibitions, which is an exhibitions business, with events in over 30 countries.

Industry

Printing & Publishing

Contact Info

Grand Buildings, 1-3 Strand

WC2N 5JR

United Kingdom

+44.20.71665500

https://www.relx.com/

Executive Leadership

Anthony J. Habgood

Non-Executive Chairman of the Board

Erik Engstrom

Chief Executive Officer, Executive Director

Nicholas L. Luff

Chief Financial Officer, Executive Director

Kumsal Bayazit Besson

Chief Executive Officer Scientific, Technical and Medical and Chairwoman, RELX Technology Forum

Youngsuk Chi

Director - Corporate Affairs and Chairman Elsevier

Key Stats

2.45 mean rating - 22 analysts
Sell
Hold
Buy
Revenue (MM, GBP)

2017

7.4K

2018

7.5K

2019

7.9K

2020(E)

7.5K
EPS (GBp)

2017

81.000

2018

84.700

2019

93.000

2020(E)

81.665
Price To Earnings (TTM)
26.33
Price To Sales (TTM)
4.45
Price To Book (MRQ)
15.98
Price To Cash Flow (TTM)
16.76
Total Debt To Equity (MRQ)
376.53
LT Debt To Equity (MRQ)
317.99
Return on Investment (TTM)
13.02
Return on Equity (TTM)
8.76

Latest News

Latest News

UPDATE 1-UK Stocks-Factors to watch on Aug. 21

Britain's FTSE 100 index is seen opening 9 points higher at 6,023 on Friday, according to financial bookmakers, with futures down 0.09% ahead of cash market open.

Relx snaps up UK's pharma analysis group SciBite

European information group Relx <REL.L> has agreed to buy Britain's SciBite, a provider of big data analytics in the pharmaceutical and healthcare industries, as part of its drive towards more digital analysis.

Relx sales fall as virus hits events business

European information group Relx <REL.L> said on Thursday its revenue fell 10% in the first half of the year as the coronavirus pandemic halted public meetings, hitting the London-listed company's exhibitions arm.

Relx half-year sales fall 10% as virus hits events arm

Relx said on Thursday its revenue fell 10% in the first half of 2020 as the coronavirus pandemic forced countries to halt public events and gatherings, hitting the European information group's exhibitions arm.

Relx scraps guidance on hit to exhibitions business

European information group Relx <REL.L> said it could not provide full-year guidance for the group due to the significant impact the coronavirus pandemic was having on its exhibitions arm.

Relx postpones nine China exhibitions, wider virus impact unclear

European information group Relx <REL.L> said it could not yet predict how coronavirus would hit its exhibitions business in China after it was forced to reschedule nine events in the country because of the outbreak.

Relx enjoys solid start to 2020, exhibitions seen trading in line

European information group Relx said the key business trends in the early part of 2020 were in line with last year as it reported organic revenue growth of 4%, in line with its recent average.

Relx spends $480 million on latest fraud spotter, Emailage

European information provider Relx Plc <REL.L> has agreed to buy U.S. company Emailage for around $480 million in its latest deal to boost the fraud detection capabilities of its fastest-growing division, a source close to the company said.

Deals of the day-Mergers and acquisitions

The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Monday:

Relx snaps up ID Analytics for $375 million

European information provider Relx <REL.L> has agreed to buy U.S.-based ID Analytics for $375 million to further boost its ability to spot fraud and produce credit scores for its fastest-growing risk division.

Chinese e-cigarette firm Relx to open 10,000 stores within three years

E-cigarette company Relx Technology said on Saturday it will open 10,000 stores globally over the next three years in a big expansion for the Chinese vaping startup.

Relx sees solid business growth continuing in 2019

European information and analytics provider Relx said business trends in the beginning of 2019 had continued in line with its 2018 performance as it reported an as-expected 4 percent rise in underlying revenue growth.

Demand for products to detect online fraud boosts Relx

Demand for products that detect and prevent online fraud helped European information provider Relx <REL.L> report a 4 percent rise in first-half underlying revenue, lifting its shares.

BRIEF-Relx Says Full Year Outlook Unchanged

* KEY BUSINESS TRENDS IN 2018 YEAR TO DATE HAVE REMAINED CONSISTENT WITH FULL YEAR 2017 ACROSS OUR BUSINESS

BRIEF-Omnicom Health Group Acquires Elsevier's Pharma Communications Business

* OMNICOM HEALTH GROUP ACQUIRES ELSEVIER'S PHARMA COMMUNICATIONS BUSINESS IN JAPAN, REBRANDS AS EMC K.K.

BRIEF-Relx Announces Non-Discretionary Share Buyback Programme

* WILL IMPLEMENT IRREVOCABLE, NON-DISCRETIONARY PROGRAMME TO REPURCHASE RESPECTIVE ORDINARY SHARES UP TO £225 MILLION IN TOTAL BETWEEN 15 FEB 2018 AND 17 APRIL 2018 Source text for Eikon: Further company coverage:

BRIEF-Relx reiterates outlook as revenue growth remains stable

* underlying revenue growth +4% in first nine months of 2017

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up